The number of CD33+ cells was positively correlated with the expression of METTL3 in tumour cells (R = 0.145, P = 0.041) and tumour-infiltrating immune cells (R = 0.182, P = 0.011) (Fig. 2b, c). The gene discussed is CD33; the disease is neoplasm.